Autem Therapeutics
Hanover
About Autem Therapeutics
Autem Therapeutics provides cancer care. The company offers autem therapy that show promise in shrinking tumors while also enhancing quality of life and extending survival in early and advanced-stage patient populations. The company resets cancer cells by normalizing their metabolism and improving energy efficiency.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: autemtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/autem-therapeutics-7383 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.